カテゴリー： Market Monitor Global, 世界, 医療/バイオ

腫瘍用標的療法の世界市場見通し2023年-2029年

◆英語タイトル：Oncology Targeted Therapy Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5828）

◆商品コード：MMG23JU5828
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：104
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Oncology Targeted Therapy Market 調査レポートは次の情報を含め、グローバルにおけるの腫瘍用標的療法市場規模と予測を収録しています。・世界の腫瘍用標的療法市場：売上、2018年-2023年、2024年-2029年
・世界の腫瘍用標的療法市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の腫瘍用標的療法市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ソラフェニブ」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

腫瘍用標的療法のグローバル主要企業は、Bayer、 Eisai、 Zelgen、 Cipla、 Natco Pharma、 AstraZeneca、 Novartis、 Roche、 Bristol-Myers Squibb、 Pfizer、 BEACON Pharma、 Jiangxi Shanxiang、 Yao Pharma、 CSPC、 CHIATAI Tianqing、 Simcereなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、腫瘍用標的療法のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の腫瘍用標的療法市場：タイプ別、2018年-2023年、2024年-2029年
世界の腫瘍用標的療法市場：タイプ別市場シェア、2022年
・ソラフェニブ、レンバチニブ、レゴラフェニブ、オシメルチニブ、アンロチニブ、アレクチニブ、その他

世界の腫瘍用標的療法市場：用途別、2018年-2023年、2024年-2029年
世界の腫瘍用標的療法市場：用途別市場シェア、2022年
・病院、小売薬局、その他

世界の腫瘍用標的療法市場：地域・国別、2018年-2023年、2024年-2029年
世界の腫瘍用標的療法市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における腫瘍用標的療法のグローバル売上、2018年-2023年
・主要企業における腫瘍用標的療法のグローバル売上シェア、2022年
・主要企業における腫瘍用標的療法のグローバル販売量、2018年-2023年
・主要企業における腫瘍用標的療法のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Bayer、 Eisai、 Zelgen、 Cipla、 Natco Pharma、 AstraZeneca、 Novartis、 Roche、 Bristol-Myers Squibb、 Pfizer、 BEACON Pharma、 Jiangxi Shanxiang、 Yao Pharma、 CSPC、 CHIATAI Tianqing、 Simcere

*************************************************************

・調査・分析レポートの概要
腫瘍用標的療法市場の定義
市場セグメント
世界の腫瘍用標的療法市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の腫瘍用標的療法市場規模
世界の腫瘍用標的療法市場規模：2022年 VS 2029年
世界の腫瘍用標的療法市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの腫瘍用標的療法の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の腫瘍用標的療法製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ソラフェニブ、レンバチニブ、レゴラフェニブ、オシメルチニブ、アンロチニブ、アレクチニブ、その他
腫瘍用標的療法のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、小売薬局、その他
腫瘍用標的療法の用途別グローバル売上・予測

・地域別市場分析
地域別腫瘍用標的療法市場規模 2022年と2029年
地域別腫瘍用標的療法売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Bayer、 Eisai、 Zelgen、 Cipla、 Natco Pharma、 AstraZeneca、 Novartis、 Roche、 Bristol-Myers Squibb、 Pfizer、 BEACON Pharma、 Jiangxi Shanxiang、 Yao Pharma、 CSPC、 CHIATAI Tianqing、 Simcere
...

Targeted therapy is a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
This report aims to provide a comprehensive presentation of the global market for Oncology Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Targeted Therapy. This report contains market size and forecasts of Oncology Targeted Therapy in global, including the following market information:
Global Oncology Targeted Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Oncology Targeted Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Sorafenib Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oncology Targeted Therapy include Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche and Bristol-Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology Targeted Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Targeted Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Oncology Targeted Therapy Market Segment Percentages, by Type, 2022 (%)
Sorafenib
Lenvatinib
Regorafenib
Osimertinib
Anlotinib
Alectinib
Other
Global Oncology Targeted Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Oncology Targeted Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Oncology Targeted Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Oncology Targeted Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Targeted Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oncology Targeted Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oncology Targeted Therapy, market overview.
Chapter 2: Global Oncology Targeted Therapy market size in revenue.
Chapter 3: Detailed analysis of Oncology Targeted Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncology Targeted Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Oncology Targeted Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Targeted Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Targeted Therapy Overall Market Size
2.1 Global Oncology Targeted Therapy Market Size: 2022 VS 2029
2.2 Global Oncology Targeted Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Targeted Therapy Players in Global Market
3.2 Top Global Oncology Targeted Therapy Companies Ranked by Revenue
3.3 Global Oncology Targeted Therapy Revenue by Companies
3.4 Top 3 and Top 5 Oncology Targeted Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oncology Targeted Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Targeted Therapy Players in Global Market
3.6.1 List of Global Tier 1 Oncology Targeted Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncology Targeted Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Oncology Targeted Therapy Market Size Markets, 2022 & 2029
4.1.2 Sorafenib
4.1.3 Lenvatinib
4.1.4 Regorafenib
4.1.5 Osimertinib
4.1.6 Anlotinib
4.1.7 Alectinib
4.1.8 Other
4.2 By Type – Global Oncology Targeted Therapy Revenue & Forecasts
4.2.1 By Type – Global Oncology Targeted Therapy Revenue, 2018-2023
4.2.2 By Type – Global Oncology Targeted Therapy Revenue, 2024-2029
4.2.3 By Type – Global Oncology Targeted Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Oncology Targeted Therapy Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application – Global Oncology Targeted Therapy Revenue & Forecasts
5.2.1 By Application – Global Oncology Targeted Therapy Revenue, 2018-2023
5.2.2 By Application – Global Oncology Targeted Therapy Revenue, 2024-2029
5.2.3 By Application – Global Oncology Targeted Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Oncology Targeted Therapy Market Size, 2022 & 2029
6.2 By Region – Global Oncology Targeted Therapy Revenue & Forecasts
6.2.1 By Region – Global Oncology Targeted Therapy Revenue, 2018-2023
6.2.2 By Region – Global Oncology Targeted Therapy Revenue, 2024-2029
6.2.3 By Region – Global Oncology Targeted Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Oncology Targeted Therapy Revenue, 2018-2029
6.3.2 US Oncology Targeted Therapy Market Size, 2018-2029
6.3.3 Canada Oncology Targeted Therapy Market Size, 2018-2029
6.3.4 Mexico Oncology Targeted Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Oncology Targeted Therapy Revenue, 2018-2029
6.4.2 Germany Oncology Targeted Therapy Market Size, 2018-2029
6.4.3 France Oncology Targeted Therapy Market Size, 2018-2029
6.4.4 U.K. Oncology Targeted Therapy Market Size, 2018-2029
6.4.5 Italy Oncology Targeted Therapy Market Size, 2018-2029
6.4.6 Russia Oncology Targeted Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Oncology Targeted Therapy Market Size, 2018-2029
6.4.8 Benelux Oncology Targeted Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Oncology Targeted Therapy Revenue, 2018-2029
6.5.2 China Oncology Targeted Therapy Market Size, 2018-2029
6.5.3 Japan Oncology Targeted Therapy Market Size, 2018-2029
6.5.4 South Korea Oncology Targeted Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Oncology Targeted Therapy Market Size, 2018-2029
6.5.6 India Oncology Targeted Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Oncology Targeted Therapy Revenue, 2018-2029
6.6.2 Brazil Oncology Targeted Therapy Market Size, 2018-2029
6.6.3 Argentina Oncology Targeted Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Oncology Targeted Therapy Revenue, 2018-2029
6.7.2 Turkey Oncology Targeted Therapy Market Size, 2018-2029
6.7.3 Israel Oncology Targeted Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Oncology Targeted Therapy Market Size, 2018-2029
6.7.5 UAE Oncology Targeted Therapy Market Size, 2018-2029
7 Oncology Targeted Therapy Companies Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Oncology Targeted Therapy Major Product Offerings
7.1.4 Bayer Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 Eisai
7.2.1 Eisai Company Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Oncology Targeted Therapy Major Product Offerings
7.2.4 Eisai Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.2.5 Eisai Key News & Latest Developments
7.3 Zelgen
7.3.1 Zelgen Company Summary
7.3.2 Zelgen Business Overview
7.3.3 Zelgen Oncology Targeted Therapy Major Product Offerings
7.3.4 Zelgen Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.3.5 Zelgen Key News & Latest Developments
7.4 Cipla
7.4.1 Cipla Company Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Oncology Targeted Therapy Major Product Offerings
7.4.4 Cipla Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.4.5 Cipla Key News & Latest Developments
7.5 Natco Pharma
7.5.1 Natco Pharma Company Summary
7.5.2 Natco Pharma Business Overview
7.5.3 Natco Pharma Oncology Targeted Therapy Major Product Offerings
7.5.4 Natco Pharma Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.5.5 Natco Pharma Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Oncology Targeted Therapy Major Product Offerings
7.6.4 AstraZeneca Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Oncology Targeted Therapy Major Product Offerings
7.7.4 Novartis Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Roche
7.8.1 Roche Company Summary
7.8.2 Roche Business Overview
7.8.3 Roche Oncology Targeted Therapy Major Product Offerings
7.8.4 Roche Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.8.5 Roche Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Oncology Targeted Therapy Major Product Offerings
7.9.4 Bristol-Myers Squibb Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Oncology Targeted Therapy Major Product Offerings
7.10.4 Pfizer Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 BEACON Pharma
7.11.1 BEACON Pharma Company Summary
7.11.2 BEACON Pharma Business Overview
7.11.3 BEACON Pharma Oncology Targeted Therapy Major Product Offerings
7.11.4 BEACON Pharma Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.11.5 BEACON Pharma Key News & Latest Developments
7.12 Jiangxi Shanxiang
7.12.1 Jiangxi Shanxiang Company Summary
7.12.2 Jiangxi Shanxiang Business Overview
7.12.3 Jiangxi Shanxiang Oncology Targeted Therapy Major Product Offerings
7.12.4 Jiangxi Shanxiang Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.12.5 Jiangxi Shanxiang Key News & Latest Developments
7.13 Yao Pharma
7.13.1 Yao Pharma Company Summary
7.13.2 Yao Pharma Business Overview
7.13.3 Yao Pharma Oncology Targeted Therapy Major Product Offerings
7.13.4 Yao Pharma Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.13.5 Yao Pharma Key News & Latest Developments
7.14 CSPC
7.14.1 CSPC Company Summary
7.14.2 CSPC Business Overview
7.14.3 CSPC Oncology Targeted Therapy Major Product Offerings
7.14.4 CSPC Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.14.5 CSPC Key News & Latest Developments
7.15 CHIATAI Tianqing
7.15.1 CHIATAI Tianqing Company Summary
7.15.2 CHIATAI Tianqing Business Overview
7.15.3 CHIATAI Tianqing Oncology Targeted Therapy Major Product Offerings
7.15.4 CHIATAI Tianqing Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.15.5 CHIATAI Tianqing Key News & Latest Developments
7.16 Simcere
7.16.1 Simcere Company Summary
7.16.2 Simcere Business Overview
7.16.3 Simcere Oncology Targeted Therapy Major Product Offerings
7.16.4 Simcere Oncology Targeted Therapy Revenue in Global Market (2018-2023)
7.16.5 Simcere Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Oncology Targeted Therapy Market Opportunities & Trends in Global Market
Table 2. Oncology Targeted Therapy Market Drivers in Global Market
Table 3. Oncology Targeted Therapy Market Restraints in Global Market
Table 4. Key Players of Oncology Targeted Therapy in Global Market
Table 5. Top Oncology Targeted Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oncology Targeted Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oncology Targeted Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oncology Targeted Therapy Product Type
Table 9. List of Global Tier 1 Oncology Targeted Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Targeted Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Oncology Targeted Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Oncology Targeted Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oncology Targeted Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Oncology Targeted Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Oncology Targeted Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oncology Targeted Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Oncology Targeted Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Oncology Targeted Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oncology Targeted Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oncology Targeted Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oncology Targeted Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oncology Targeted Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oncology Targeted Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oncology Targeted Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Bayer Company Summary
Table 31. Bayer Oncology Targeted Therapy Product Offerings
Table 32. Bayer Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer Key News & Latest Developments
Table 34. Eisai Company Summary
Table 35. Eisai Oncology Targeted Therapy Product Offerings
Table 36. Eisai Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Eisai Key News & Latest Developments
Table 38. Zelgen Company Summary
Table 39. Zelgen Oncology Targeted Therapy Product Offerings
Table 40. Zelgen Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Zelgen Key News & Latest Developments
Table 42. Cipla Company Summary
Table 43. Cipla Oncology Targeted Therapy Product Offerings
Table 44. Cipla Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Cipla Key News & Latest Developments
Table 46. Natco Pharma Company Summary
Table 47. Natco Pharma Oncology Targeted Therapy Product Offerings
Table 48. Natco Pharma Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Natco Pharma Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Oncology Targeted Therapy Product Offerings
Table 52. AstraZeneca Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Oncology Targeted Therapy Product Offerings
Table 56. Novartis Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Roche Company Summary
Table 59. Roche Oncology Targeted Therapy Product Offerings
Table 60. Roche Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Roche Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Summary
Table 63. Bristol-Myers Squibb Oncology Targeted Therapy Product Offerings
Table 64. Bristol-Myers Squibb Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol-Myers Squibb Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Oncology Targeted Therapy Product Offerings
Table 68. Pfizer Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. BEACON Pharma Company Summary
Table 71. BEACON Pharma Oncology Targeted Therapy Product Offerings
Table 72. BEACON Pharma Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. BEACON Pharma Key News & Latest Developments
Table 74. Jiangxi Shanxiang Company Summary
Table 75. Jiangxi Shanxiang Oncology Targeted Therapy Product Offerings
Table 76. Jiangxi Shanxiang Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Jiangxi Shanxiang Key News & Latest Developments
Table 78. Yao Pharma Company Summary
Table 79. Yao Pharma Oncology Targeted Therapy Product Offerings
Table 80. Yao Pharma Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Yao Pharma Key News & Latest Developments
Table 82. CSPC Company Summary
Table 83. CSPC Oncology Targeted Therapy Product Offerings
Table 84. CSPC Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. CSPC Key News & Latest Developments
Table 86. CHIATAI Tianqing Company Summary
Table 87. CHIATAI Tianqing Oncology Targeted Therapy Product Offerings
Table 88. CHIATAI Tianqing Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. CHIATAI Tianqing Key News & Latest Developments
Table 90. Simcere Company Summary
Table 91. Simcere Oncology Targeted Therapy Product Offerings
Table 92. Simcere Oncology Targeted Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Simcere Key News & Latest Developments
List of Figures
Figure 1. Oncology Targeted Therapy Segment by Type in 2022
Figure 2. Oncology Targeted Therapy Segment by Application in 2022
Figure 3. Global Oncology Targeted Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oncology Targeted Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Oncology Targeted Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncology Targeted Therapy Revenue in 2022
Figure 8. By Type - Global Oncology Targeted Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Oncology Targeted Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Oncology Targeted Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Oncology Targeted Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Oncology Targeted Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Oncology Targeted Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Oncology Targeted Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Oncology Targeted Therapy Revenue Market Share, 2018-2029
Figure 16. US Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Oncology Targeted Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Oncology Targeted Therapy Revenue Market Share, 2018-2029
Figure 28. China Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Oncology Targeted Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Oncology Targeted Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Oncology Targeted Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Bayer Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eisai Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Zelgen Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cipla Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Natco Pharma Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Roche Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol-Myers Squibb Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Pfizer Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. BEACON Pharma Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Jiangxi Shanxiang Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Yao Pharma Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. CSPC Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. CHIATAI Tianqing Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Simcere Oncology Targeted Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 腫瘍用標的療法の世界市場見通し2023年-2029年(Oncology Targeted Therapy Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

腫瘍用標的療法の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp